Swipe to discover more

• First-of-its-Kind Health Economic Analysis Shows Early Use of Fast Diagnostics in Sepsis Care Could Save Thousands of Lives and Reduce Health System Costs Across G7 Countries

  bioMérieux, a world leader in in vitro diagnostics, announces the publication of a multi-country health economic analysis assessing the impact of deploying fast identification and antimicrobial susceptibility testing (ID/AST) early in the care pathway for patients with bloodstream infections at high-risk of sepsis.

  Read the press release
  

• The Evolution of MALDI‑TOF in the Clinical Microbiology Laboratory

  The introduction of matrix‑assisted laser desorption/ionization time‑of‑flight mass spectrometry (MALDI‑TOF MS) marked a fundamental shift in how laboratories identify microorganisms, transforming workflows that once emphasized stepwise exclusion into ones driven by rapid, data‑rich pattern recognition.

  Read the blog post
  

• Predicting Sepsis-Related Shock Earlier: How AI Could Transform Critical Care

  In the ICU, minutes count — particularly for patients with sepsis, where a sudden drop in blood pressure can signal a dangerous turn. If care teams can see that change coming, even by a couple of hours, they can prepare, personalize treatment, and potentially prevent a crisis. That’s where interpretable, clinically grounded AI can help — turning routine hospital data into early warning signs.

  Read the news